Becton Dickinson (BDX) Cash from Financing Activities (2009 - 2026)
Becton Dickinson's (BDX) quarterly Cash from Financing Activities came in at -$414.0 million in Q1 2026, down 989.47% year-on-year from $46.5 million in Q1 2025, and down 37.09% on a QoQ basis from -$302.0 million in Q4 2025.
Becton Dickinson (BDX) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Cash from Financing Activities data on file, last reported at -$414.0 million in Q1 2026.
- On a quarterly basis, Cash from Financing Activities fell 989.47% year-over-year to -$414.0 million in Q1 2026; TTM through Mar 2026 was -$2.4 billion, a 227.84% decrease from a year earlier, with the FY2025 full-year figure at -$3.6 billion, down 273.31% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$414.0 million, down from -$302.0 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for BDX reached as high as $1.7 billion in Q1 2024 and fell as low as -$1.9 billion in Q4 2024.
- Historically, Cash from Financing Activities has averaged -$271.2 million across 5 years, with a median of -$534.0 million in 2022.
- Across the five-year window, Cash from Financing Activities jumped 427.57% in 2022 and slumped 989.47% in 2026, its largest moves.
- Year by year, Cash from Financing Activities stood at -$534.0 million in 2022, then slumped by 61.42% to -$862.0 million in 2023, then plunged by 123.67% to -$1.9 billion in 2024, then soared by 84.34% to -$302.0 million in 2025, then tumbled by 37.09% to -$414.0 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$414.0 million in Q1 2026, -$302.0 million in Q4 2025, and -$809.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | -11.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -414.00 Mn |
| Mar 31, 2026 | -414.00 Mn |
| Dec 31, 2025 | -302.00 Mn |
| Dec 31, 2025 | -302.00 Mn |
| Sep 30, 2025 | -809.00 Mn |
| Sep 30, 2025 | -809.00 Mn |
| Jun 30, 2025 | -842.00 Mn |
| Jun 30, 2025 | -842.00 Mn |
| Mar 31, 2025 | -38.00 Mn |
| Mar 31, 2025 | -38.00 Mn |
| Dec 31, 2024 | -1.93 Bn |
| Dec 31, 2024 | -1.93 Bn |
| Sep 30, 2024 | 124.00 Mn |
| Sep 30, 2024 | 124.00 Mn |
| Jun 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | 1.12 Bn |
| Mar 31, 2024 | 1.71 Bn |
| Mar 31, 2024 | 1.71 Bn |
| Dec 31, 2023 | -862.00 Mn |
| Dec 31, 2023 | -862.00 Mn |